This is a thymic neuroendocrine tumor (thymic carcinoid) represented on a hematoxylin and eosin stained histology slide prepared from thymic tissue. The specimen is a thymic lesion in the anterior mediastinum. The tumor displays organoid nesting and ribbon-like arrangements (zellballen/perivascular rosettes) of uniform small cells with round to oval nuclei, finely dispersed chromatin (salt-and-pepper appearance), and scant cytoplasm. Cells are densely packed in interlacing cords and fascicles with delicate fibrovascular stroma; mitotic figures are infrequent in this field; necrosis is not conspicuous. The image shows a cohesive neuroendocrine morphology with minimal pleomorphism and absence of overt squamous differentiation. Immunophenotype in practice would be positive for neuroendocrine markers (chromogranin A, synaptophysin) and cytokeratins, supporting thymic carcinoid. The differential diagnosis includes spindle cell thymoma (type A) when spindle cells predominate, paraganglioma, medullary thyroid carcinoma with amyloid stroma, metastatic mucinous adenocarcinoma, and angiomatoid variants mimicking hemangioma. Clinically, thymic carcinoids are aggressive, may recur or metastasize, and require surgical excision with possible adjuvant therapy. This image is relevant for educational purposes in surgical pathology, mediastinal tumors, and neuroendocrine tumor biology, enabling recognition of organoid nesting, ribbon/festoons growth, salt-and-pepper chromatin, and differential with thymic spindle tumors and paragangliomas. High clinical relevance for diagnosis and management.

Imaging modality: Bright-field light microscopy of hematoxylin and eosin–stained ovarian tissue sections. Anatomical location: ovary (pelvic region), primary tumor in ovarian parenchyma. Visual features: orderly nests and cords of uniform neuroendocrine cells with round to oval nuclei, scant to moderate cytoplasm, and characteristic finely stippled (salt‑and‑pepper) chromatin; rosette-like structures and trabecular arrangements embedded in delicate stroma; occasional small vascular channels; low-to-moderate mitotic activity; absence or minimal necrosis. Pathology and tissue architecture: organoid nesting with nesting patterns typical of carcinoid tumors; absence of significant mucin production; lack of solid pleomorphic sheets. Pathological findings: consistent with primary ovarian carcinoid tumor (neuroendocrine neoplasm), type insular or trabecular possible; limited atypia; immunohistochemical confirmation typically positive for neuroendocrine markers such as synaptophysin and chromogranin A. Diagnostic significance: histology supports diagnosis of ovarian neuroendocrine tumor; differentiate from metastatic neuroendocrine tumors to the ovary; prognosis depends on size, histologic pattern, and stage; differential diagnoses include granulosa cell tumor with neuroendocrine differentiation and mucinous/serous tumors with focal neuroendocrine features. Clinical correlation: many patients are peri‑ or postmenopausal; potential for carcinoid syndrome with larger tumors; surgical management essential; evaluate for MEN1 syndrome in rare cases; urine 5-HIAA may be elevated; imaging and IHC recommended for confirmation and staging; educational utility in teaching ovarian neuroendocrine neoplasms.

A histologic section of lung tissue stained with Hematoxylin and Eosin, examined under light microscopy at high magnification (approximately 400x). The tumor displays neuroendocrine morphology with organoid nesting and trabecular growth patterns. Tumor cells are uniform, polygonal with moderate cytoplasm and round nuclei with finely dispersed, salt-and-pepper chromatin. Notable mitotic activity is present, ranging from 2 to 10 mitoses per 10 high-power fields, and punctate necrosis is evident within some tumor nodules. The architectural arrangement suggests a well-differentiated neuroendocrine neoplasm consistent with an atypical carcinoid, as opposed to a typical carcinoid which lacks necrosis and shows lower mitotic rates. Immunohistochemical studies (not shown) would typically show neuroendocrine marker positivity (chromogranin A, synaptophysin, CD56) supporting a neuroendocrine neoplasm. The combination of mitotic activity and necrosis distinguishes atypical carcinoid from typical carcinoid, which lacks significant necrosis and has lower mitotic rates. This histology correlates with a higher risk of nodal and distant metastasis and a more aggressive clinical course, with a 5-year survival around 60% in reported series. Smoking history is more commonly associated compared with typical carcinoids but not universal. TP53 and RB1 mutations are seen in a subset (~20%) of atypical carcinoids. This image is representative for educational purposes in pathology, pulmonology, oncology, and medical training to illustrate diagnostic criteria and prognostic implications.